Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy
Farheen Shamsi, Phool Hasan, Aarfa Queen, et al.
Bioorganic Chemistry (2020) Vol. 98, pp. 103754-103754
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
Yichao Wan, Guoqing Fang, Hongjuan Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113837-113837
Closed Access | Times Cited: 136
Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
Mohd Yousuf, Anas Shamsi, Parvez Κhan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3526-3526
Open Access | Times Cited: 93
Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review
Jingjing Wang, Wen Sun, Wei-Dong Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2304-2319
Open Access | Times Cited: 49
A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents
Tejas M. Dhameliya, Shrddhaba J. Chudasma, Tanvi M. Patel, et al.
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2967-2980
Open Access | Times Cited: 48
pH regulators and their inhibitors in tumor microenvironment
Senyi Liao, Guang Wu, Zhizhong Xie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116170-116170
Closed Access | Times Cited: 12
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors
Bin Zhang, Zhikun Liu, Shengjin Xia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113300-113300
Closed Access | Times Cited: 45
Synthesis, anticancer and anti-inflammatory evaluation of novel quinoxaline-1,3,4-oxadiazole derivatives as EGFR and COX-2 inhibitors
Mamdouh F. A. Mohamed, Eman A. Ahmed, Omar Alshazly, et al.
Journal of Molecular Structure (2025), pp. 141651-141651
Closed Access
Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4
Saleha Anwar, Shama Khan, Farah Anjum, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 359-374
Closed Access | Times Cited: 37
Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
Mohd Yousuf, Anas Shamsi, Aarfa Queen, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 8, pp. 897-910
Closed Access | Times Cited: 32
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Water Extract from Inflorescences of Industrial Hemp Futura 75 Variety as a Source of Anti-Inflammatory, Anti-Proliferative and Antimycotic Agents: Results from In Silico, In Vitro and Ex Vivo Studies
Giustino Orlando, Lucia Recinella, Annalisa Chiavaroli, et al.
Antioxidants (2020) Vol. 9, Iss. 5, pp. 437-437
Open Access | Times Cited: 31
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
Mikhail Krasavin, Stanislav Kalinin, Tatiana V. Sharonova, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 1555-1561
Open Access | Times Cited: 29
Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part C: Multicomponent Sulfonamide Hybrids
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 37, pp. 4181-4255
Closed Access | Times Cited: 17
Development of Oxadiazole-Sulfonamide-Based Compounds as Potential Antibacterial Agents
Asghar Ali, Phool Hasan, Mohammad Irfan, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 27798-27813
Open Access | Times Cited: 20
Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells
Min Zhou, Joelle C. Boulos, Ejlal A. Omer, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5658-5658
Open Access | Times Cited: 8
DFT Computational Studies, Spectroscopic (UV–Vis, IR, NMR), In Silico Molecular Docking and ADME Study of 3-(3-Methylpyridin-2-yl)-5-phenyl-1,2,4-oxadiazole
Ravindra Haribhau Waghchaure, Vishnu A. Adole
Journal of Molecular Structure (2023) Vol. 1296, pp. 136724-136724
Closed Access | Times Cited: 8
Recent development of azole–sulfonamide hybrids with the anticancer potential
Chenyuan Zhao, Liu Yang, Zhuo Cui
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1267-1281
Closed Access | Times Cited: 2
Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma
Sarfraz Ahmed, Aarfa Queen, Iram Irfan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 25945-25959
Open Access | Times Cited: 2
Discovery of Natural Compounds as Potential Inhibitors of Human Carbonic Anhydrase II: An Integrated Virtual Screening, Docking, and Molecular Dynamics Simulation Study
Farah Anjum, Fatima Adam Mohamed Ali, Taj Mohammad, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 8, pp. 513-524
Closed Access | Times Cited: 17
Structure-guided design and development of vanillin-triazole conjugates as potential MARK4 inhibitors targeting hepatocellular carcinoma
Sarfraz Ahmed, Parvez Κhan, Iram Irfan, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136303-136303
Closed Access | Times Cited: 6
Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: towards therapeutic management of diabetes and obesity
Amarjyoti Das Mahapatra, Aarfa Queen, Mohd Yousuf, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 3144-3154
Closed Access | Times Cited: 16
Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents
Garima Kapoor, Rubina Bhutani, Dharam Pal Pathak, et al.
Polycyclic aromatic compounds (2021) Vol. 42, Iss. 7, pp. 4183-4215
Closed Access | Times Cited: 14
Antimicrobial, Antioxidant, and Antiproliferative Effects of Coronilla minima: An Unexplored Botanical Species
Claudio Ferrante, Paola Angelini, Roberto Venanzoni, et al.
Antibiotics (2020) Vol. 9, Iss. 9, pp. 611-611
Open Access | Times Cited: 15
Synergistic antimicrobial activity, MD simulation studies and crystal structure of natural alcohol motif containing novel substituted cinnamates
Iram Irfan, Asghar Ali, Ayesha Ubaid, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 211-230
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top